Hamza, S. Et Al. 2022. Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα. CELL DEATH DISCOVERY , 2.

Hamza, S., Garanina, E. E., Khaiboullina, S. F., & TEZCAN, G., (2022). Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα. CELL DEATH DISCOVERY , 2.

Hamza, Shaimaa Et Al. "Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα," CELL DEATH DISCOVERY , 2, 2022

Hamza, Shaimaa Et Al. "Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα." CELL DEATH DISCOVERY , pp.2, 2022

Hamza, S. Et Al. (2022) . "Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα." CELL DEATH DISCOVERY , p.2.

@article{article, author={Shaimaa Hamza Et Al. }, title={Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ERα}, journal={CELL DEATH DISCOVERY}, year=2022, pages={2} }